Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 28851-28900 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT05989763
Interrogating the Pathophysiological Mechanisms of Constipation in Patients With Systemic Sclerosis
NARecruiting
60 participants
Started: Feb 17, 2024 · Completed: Sep 1, 2029
4 conditions2 sponsors1 location
NCT06265636
Electrical Stimulation of the Mandibular Nerve for Pain and Function Management in Temporomandibular Disorders
NARecruiting
40 participants
Started: Feb 17, 2024 · Completed: May 1, 2027
1 condition2 sponsors1 location
NCT06240637
Telemonitoring Utility in the Process of Adaptation to Home Mechanical Ventilation (HMV)
NARecruiting
48 participants
Started: Feb 17, 2024 · Completed: Dec 1, 2026
1 condition3 sponsors1 location
NCT06104956
Weaning Protocol for High-flow Nasal Oxygen Therapy in Intensive Care
NARecruiting
370 participants
Started: Feb 17, 2024 · Completed: Mar 31, 2027
2 conditions1 sponsor11 locations
NCT06304350
Pembrolizumab Combined With Preoperative Chemotherapy (Albumin Paclitaxel+Carboplatin) Neoadjuvant Therapy for Resectable Locally Advanced (Stage II/III) Esophageal Squamous Cell Carcinoma
PHASE2Recruiting
25 participants
Started: Feb 17, 2024 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT06260839
the Effect of Minimally Invasive Technique Assisted by Magnetic Resonance Neurography
NARecruiting
44 participants
Started: Feb 16, 2024 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT05595005
Neural Bases of Post-stroke Emotion Perception Disorders
N/ARecruiting
80 participants
Started: Feb 16, 2024 · Completed: Oct 31, 2025
3 conditions2 sponsors1 location
NCT06239220
PD-L1 t-haNK, N-803 IL-15sa and Cetuximab for Recurrent, Metastatic HNSCC
PHASE2Recruiting
25 participants
Started: Feb 16, 2024 · Completed: Jan 31, 2027
6 conditions2 sponsors2 locations
NCT06007976
LLLT to Reduce Low Back Pain
NARecruiting
60 participants
Started: Feb 16, 2024 · Completed: Dec 31, 2026
1 condition2 sponsors1 location
NCT06281509
Palmaris Longus Muscle and Dupuytren
NARecruiting
240 participants
Started: Feb 16, 2024 · Completed: Jun 1, 2025
1 condition1 sponsor1 location
NCT06261216
Association Between Lifetime Physical Activity and Exercise and the Development of Wild-type Transthyretin Amyloid Cardiomyopathy
N/ARecruiting
189 participants
Started: Feb 16, 2024 · Completed: May 31, 2025
2 conditions2 sponsors1 location
NCT05901519
A Pilot Study of Liver Protection Using Prednisone for Patients Receiving Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma
PHASE2Recruiting
20 participants
Started: Feb 16, 2024 · Completed: Aug 31, 2026
1 condition1 sponsor1 location
NCT06281366
Diamine Oxidase and Adverse Pregnancy Outcomes
N/ARecruiting
75 participants
Started: Feb 16, 2024 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT04706013
Oral Pyridoxal 5'-Phosphate for the Treatment of Patients With PNPO Deficiency
PHASE3Recruiting
15 participants
Started: Feb 16, 2024 · Completed: Nov 30, 2026
1 condition1 sponsor7 locations
NCT05835037
Effect of Zinc on Glucose Homeostasis
PHASE4Recruiting
200 participants
Started: Feb 16, 2024 · Completed: Jul 31, 2028
2 conditions1 sponsor1 location
NCT05910619
Transcranial Pulse Stimulation of the Brain
NARecruiting
20 participants
Started: Feb 16, 2024 · Completed: Jul 7, 2026
2 conditions1 sponsor1 location
NCT06230016
Adhesion of Children and Adolescents Treated for Cancer to Personalized Support in Adapted Physical Activity Program
N/ARecruiting
48 participants
Started: Feb 16, 2024 · Completed: Jan 31, 2026
2 conditions2 sponsors1 location
NCT05853575
Trial of Two Adagrasib Dosing Regimens in NSCLC With KRAS G12C Mutation (KRYSTAL 21)
PHASE2Recruiting
200 participants
Started: Feb 16, 2024 · Completed: Jul 30, 2026
3 conditions1 sponsor120 locations
NCT06085716
Combination Therapy for Cancer Related Fatigue in Patients With Metastatic Cancers
PHASE2/PHASE3Recruiting
240 participants
Started: Feb 16, 2024 · Completed: Aug 31, 2029
2 conditions1 sponsor1 location
NCT06311058
Protein Supplementation After ACL Surgery
NARecruiting
102 participants
Started: Feb 16, 2024 · Completed: Dec 1, 2027
1 condition1 sponsor1 location
NCT06270641
Increasing Physical Activity for Adults With Multiple Sclerosis (MS)
NARecruiting
106 participants
Started: Feb 16, 2024 · Completed: Sep 30, 2026
3 conditions1 sponsor1 location
NCT06208345
Early Life Intervention in Pediatrics Supported by E-health
NARecruiting
148 participants
Started: Feb 16, 2024 · Completed: Dec 31, 2028
7 conditions2 sponsors1 location
NCT07191223
Evaluation of Knowledge on Tick-borne Encephalitis Virus (TBEV) Infection Among General Practitioners in France
N/ARecruiting
100 participants
Started: Feb 16, 2024 · Completed: Feb 16, 2026
1 condition1 sponsor1 location
NCT06121011
A Global Prospective Observational Registry of Patients With Pompe Disease
N/ARecruiting
500 participants
Started: Feb 16, 2024 · Completed: Dec 20, 2034
1 condition1 sponsor40 locations
NCT06336382
Tau Biomarkers in Late-onset Psychosis (LOP)
N/ARecruiting
16 participants
Started: Feb 16, 2024 · Completed: Jun 30, 2027
2 conditions2 sponsors1 location
NCT06280677
Aurora Test for ART Donor Patients (AURORA-Donor)
N/ARecruiting
160 participants
Started: Feb 16, 2024 · Completed: Sep 30, 2026
1 condition3 sponsors1 location
NCT06328088
Vegetarian Versus Non Vegetarian Based Diet in the Recurrence of Hepatic Encephalopathy in Patients With Cirrhosis: An Open Label Pilot Study
N/ARecruiting
40 participants
Started: Feb 16, 2024 · Completed: Oct 16, 2024
1 condition1 sponsor1 location
NCT06157866
Cognitive Training to Enhance Brain Concordance During Acupuncture
NARecruiting
100 participants
Started: Feb 16, 2024 · Completed: Jun 30, 2027
1 condition2 sponsors3 locations
NCT06091930
A Study to Test Different Doses of BI 765049 Alone and in Combination With Ezabenlimab in Asian People With Advanced Cancer (Solid Tumours) Positive for B7-H6
PHASE1Recruiting
70 participants
Started: Feb 16, 2024 · Completed: Sep 10, 2028
6 conditions1 sponsor9 locations
NCT06303921
Study of Biodistribution, Metabolism, Excretion and Brain Uptake11C-M503
EARLY_PHASE1Recruiting
70 participants
Started: Feb 16, 2024 · Completed: Feb 28, 2029
1 condition1 sponsor3 locations
NCT06112522
Tirbanubulin (Klisiry®) in the Treatment of Basal Cell Carcinoma
PHASE2Recruiting
50 participants
Started: Feb 16, 2024 · Completed: Dec 1, 2025
1 condition1 sponsor1 location
NCT06046170
Adaptation and Feasibility of the Community-Based Anxiety Program Tailored for Autism (CAPTA)
NARecruiting
60 participants
Started: Feb 16, 2024 · Completed: Dec 31, 2025
5 conditions3 sponsors3 locations
NCT06121297
RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus
PHASE1/PHASE2Recruiting
12 participants
Started: Feb 16, 2024 · Completed: Dec 31, 2027
2 conditions1 sponsor22 locations
NCT06264804
Risk Factors for Progressive Suction Loss in Corneal Refractive Surgery
N/ARecruiting
800 participants
Started: Feb 16, 2024 · Completed: Dec 1, 2024
1 condition1 sponsor1 location
NCT06120140
Enhanced Dermatological Care to Reduce Rash and Paronychia in Epidermal Growth Factor Receptor (EGRF)-Mutated Non-Small Cell Lung Cancer (NSCLC) Treated First-line With Amivantamab Plus Lazertinib
PHASE2Recruiting
300 participants
Started: Feb 16, 2024 · Completed: Jan 31, 2032
1 condition1 sponsor93 locations
NCT06262360
Changes in Pulmonary Ventilation Distribution Assessed by Electrical Impedance Tomography in Healthy Children Under General Anesthesia
NARecruiting
60 participants
Started: Feb 16, 2024 · Completed: Sep 30, 2024
1 condition1 sponsor1 location
NCT06014255
Trial of Neoadjuvant Enoblituzumab vs SOC in Men With High-Risk Localized Prostate Cancer
PHASE2Recruiting
219 participants
Started: Feb 16, 2024 · Completed: Mar 1, 2029
1 condition2 sponsors5 locations
NCT06262165
Evaluation of Liver Damage in Patients With Anorexia Nervosa by Blood Biomarker Analysis
N/ARecruiting
50 participants
Started: Feb 16, 2024 · Completed: Dec 15, 2032
1 condition1 sponsor1 location
NCT06247358
Frailty, Physical Capacity and Lung Function in Postoperative Cardiac Surgery Patients
N/ARecruiting
200 participants
Started: Feb 16, 2024 · Completed: Oct 10, 2026
4 conditions1 sponsor1 location
NCT06321978
Mepilex Border Flex Utilization Pilot Spain
N/ARecruiting
40 participants
Started: Feb 16, 2024 · Completed: May 31, 2024
1 condition1 sponsor1 location
NCT06244485
A Study of Valemetostat Tosylate in Combination With DXd ADCs in Subjects With Solid Tumors
PHASE1Recruiting
210 participants
Started: Feb 16, 2024 · Completed: Nov 1, 2028
1 condition1 sponsor38 locations
NCT06711861
Multicenter Retrospective Study on Streptobacillus Moniliformis Infections in France
N/ARecruiting
20 participants
Started: Feb 16, 2024 · Completed: Feb 16, 2025
1 condition1 sponsor1 location
NCT06222749
Oxytocin and Reward Processing in Women
NARecruiting
100 participants
Started: Feb 16, 2024 · Completed: Dec 31, 2026
2 conditions4 sponsors1 location
NCT06278545
Trial Evaluating Modified FOLFIRINOX and Modified FOLFOX in the Treatment of Locally Advanced or Metastatic Small Bowel Adenocarcinoma
PHASE2Recruiting
130 participants
Started: Feb 16, 2024 · Completed: Feb 28, 2029
1 condition1 sponsor1 location
NCT06051240
Lithium Treatment to Prevent Cognitive Impairment After Brain Radiotherapy
PHASE2Recruiting
84 participants
Started: Feb 16, 2024 · Completed: Aug 31, 2033
7 conditions2 sponsors2 locations
NCT06049082
A Study of KB408 for the Treatment of Alpha-1 Antitrypsin Deficiency
PHASE1Recruiting
15 participants
Started: Feb 15, 2024 · Completed: Dec 31, 2026
1 condition1 sponsor3 locations
NCT05836896
A Phase I Trial to Establish the Safety and Maximum Tolerated Dose of High-affinity Autologous BCMA-targeting Chimeric Antigen Receptor (CAR) T-cells in Patients With Relapsed and Refractory B-cell Malignancies
PHASE1Recruiting
16 participants
Started: Feb 15, 2024 · Completed: Jun 30, 2027
5 conditions2 sponsors1 location
NCT06161506
Surface Electrical Stimulation for Urinary Incontinence in Men Treated for Prostate Cancer
PHASE2Recruiting
41 participants
Started: Feb 15, 2024 · Completed: Mar 1, 2026
3 conditions1 sponsor1 location
NCT06298409
Evaluating the Effect Of Rifaximin on the Gut Microbiota and Metabolome in SIBO Using CapScan®
PHASE1Recruiting
34 participants
Started: Feb 15, 2024 · Completed: Feb 28, 2026
1 condition1 sponsor1 location
NCT06394011
Study of VA Combined With HAAG Regimen in Newly Diagnosed Intermediate and High-risk AML Patients
PHASE2Recruiting
60 participants
Started: Feb 15, 2024 · Completed: Dec 30, 2026
2 conditions1 sponsor1 location